<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對(duì)照品 > 對(duì)照品 > 國(guó)家對(duì)照品 >
    Des(sulfonylethyl)amino Hydroxy Lapatinib
    產(chǎn)品基本信息
    產(chǎn)品編號(hào):D297423
    產(chǎn)品名稱:Des(sulfonylethyl)amino Hydroxy Lapatinib
    產(chǎn)品CAS:320337-48-2
    規(guī)格含量:25mg
    產(chǎn)品價(jià)格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號(hào): D297423
    名稱: Des(sulfonylethyl)amino Hydroxy Lapatinib
    別名: 5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furanmethanol;
    CAS號(hào): 320337-48-2
    分子式: C??H??ClFN?O?
    分子量: 475.9
    種類: Standards; Pharmaceutical/API Drug Impurities/Metabolites;
    應(yīng)用: Des(sulfonylethyl)amino Hydroxy Lapatinib is a compound related to drug Lapatinib (L175808), which is a selective inhibitor of epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinases. Lapatinib is used to treat breast cancer, especially metastatic breast cancer that has progressed after trastuzumab treatment and other chemotherapy.
    參考文獻(xiàn)


    2011-2018 信陽(yáng)萊耀生物科技有限公司 @ 信陽(yáng)埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對(duì)照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對(duì)照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      欧美性爱 综合 | 99视频免费在线观看 | 国产肏逼视频 | 青青手机视频 | chinese勾搭少妇vid |